ODDB.org: Open Drug Database

Laurak 250 mg, Granulat zur Herstellung einer Lösung zum Einnehmen - 2 x 90

Swissmedic Key	69242004	Registration Holder	Neuraxpharm Switzerland AG
Name	Laurak 250 mg, Granulat zur Herstellung einer Lösung zum Einnehmen	Date of registration	17.10.2024
		Introduction of Sequence	17.10.2024
ATC-Classification	Levetiracetam (N03AX14)	Revision date
WHO	WHO-DDD	Valid until	16.10.2029
Index Therapeuticus (BSV)	01.07.10.	Show package size	2 x 90
Index Therapeuticus (Swissmedic)	01.07.10.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680692420046	Medication Code	Synthetika
Pharmacode		Disponibility

Composition

levetiracetamum 250 mg, isomaltum 725 mg, aromatica cum saccharum 1.2 mg, ammonii glycyrrhizas, acesulfamum kalicum, ad granulatum pro charta.

Packungsbestandteile

Galenic Form

Granulat zur Herstellung einer Lösung zum Einnehmen

Excipiens

Active Agent	Dose
Levetiracetame	250 mg

BAG: Active Agent	Dose
Levetiracetame	250 mg

Inactive agents	Dose
Acesulfamum Kalicum
Ad Granulatum
Ammonii Glycyrrhizas
Aromatica cum Saccharum	1.2 mg
Isomaltum	725 mg

Source

Data was imported : 06.11.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH